ABLYNX N.V.

It is used to treat an episode of acquired thrombotic thrombocytopenic purpura in adults and adolescents aged 12 years and older weighing at least 40 kg. This medicine prevents the formation of blood clots in small blood vessels.

Dosage form: solution for injection, powder and solvent

ATC: B01AX07